J S Read

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1
    J S Read
    Center for Research for Mothers and Children, Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 7510, USA
    Cochrane Database Syst Rev . 2005
  2. ncbi request reprint The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 17:391-7. 1998
  3. ncbi request reprint Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
    J S Read
    Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 18:134-42. 1999
  4. ncbi request reprint Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 19:544-51. 2000
  5. ncbi request reprint Cesarean section delivery to prevent vertical transmission of human immunodeficiency virus type 1. Associated risks and other considerations
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    Ann N Y Acad Sci 918:115-21. 2000
  6. ncbi request reprint Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    J Acquir Immune Defic Syndr 26:236-45. 2001
  7. ncbi request reprint Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings
    L M Mofenson
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852, USA
    Lancet 362:1625-7. 2003
  8. pmc Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum
    J S Read
    Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 7510, USA
    HIV Med 9:875-82. 2008
  9. ncbi request reprint Acceptance of HIV-1 education & voluntary counselling/testing by & seroprevalence of HIV-1 among, pregnant women in rural south India
    N M Samuel
    The Tamil Nadu Dr M G R Medical University, Chennai, India
    Indian J Med Res 125:49-64. 2007
  10. pmc Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics
    E V Capparelli
    San Diego Schools of Medicine and Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA 92103, USA
    HIV Med 9:214-20. 2008

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1
    J S Read
    Center for Research for Mothers and Children, Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 7510, USA
    Cochrane Database Syst Rev . 2005
    ....
  2. ncbi request reprint The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 17:391-7. 1998
    ..The objectives of the study were to evaluate the immunogenicity of Hib conjugate vaccines among HIV-infected children according to clinical and immunologic disease progression as well as viral load...
  3. ncbi request reprint Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
    J S Read
    Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 18:134-42. 1999
    ....
  4. ncbi request reprint Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 19:544-51. 2000
    ....
  5. ncbi request reprint Cesarean section delivery to prevent vertical transmission of human immunodeficiency virus type 1. Associated risks and other considerations
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    Ann N Y Acad Sci 918:115-21. 2000
    ..In summary, the benefit of ECS must be weighed against potential risks, and issues such as cost-effectiveness also should be taken into consideration...
  6. ncbi request reprint Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    J Acquir Immune Defic Syndr 26:236-45. 2001
    ....
  7. ncbi request reprint Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings
    L M Mofenson
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852, USA
    Lancet 362:1625-7. 2003
    ..0001) and serum albumin (p=0.0107) independently predicted mortality. Further assessment of these markers is warranted in resource-poor settings...
  8. pmc Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum
    J S Read
    Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 7510, USA
    HIV Med 9:875-82. 2008
    ..Our objective was to evaluate the pharmacokinetics of nelfinavir (NFV) (625 mg tablets) 1250 mg twice daily during pregnancy and postpartum...
  9. ncbi request reprint Acceptance of HIV-1 education & voluntary counselling/testing by & seroprevalence of HIV-1 among, pregnant women in rural south India
    N M Samuel
    The Tamil Nadu Dr M G R Medical University, Chennai, India
    Indian J Med Res 125:49-64. 2007
    ....
  10. pmc Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics
    E V Capparelli
    San Diego Schools of Medicine and Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA 92103, USA
    HIV Med 9:214-20. 2008
    ..To determine the impact of pregnancy on the pharmacokinetics (PK) of nevirapine (NVP) during chronic dosing in HIV-infected women and appropriate NVP dosing in this population...